Skip to main content

Advertisement

SpringerLink
Log in

The Optimal Age Threshold for Stratifying the Risks of Disease Progression in Patients with Highly Suspicious Sub-centimeter Thyroid Nodules

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The study aimed to identify the value and optimal age cutoff to predict the progression of highly suspicious thyroid nodules ≤ 10 mm during active surveillance (AS), and to reveal distinct risk factors in patients of different ages.

Methods

A total of 779 patients with highly suspicious thyroid nodules were enrolled and followed up by ultrasonography. Locally weighted scatterplot smoothing (LOWESS) and the package ‘changepoint’ were used to identify the optimal age cutoffs using R. Multivariate Cox regression was performed to identify independent prognostic factors in each patient group divided according to age.

Results

Age was an independent predictor of nodule progression (P = 0.038). The optimal age cutoff to stratify the risk of nodule progression was 30 years. Younger patients were more likely to have progression of nodules during AS (P < 0.001), including enlargement of nodule size (P = 0.011) and new lesion occurrence (P < 0.001). Nodule size was identified as a risk factor for disease progression in patients younger than 30 years old (P = 0.008, OR 7.946, 95% CI 1.715–36.820), while multifocality (P = 0.018, OR 2.315, 95% CI 1.155–4.639) and thyroiditis (P = 0.028, OR 2.265, 95% CI 1.092–4.699) were independent predictors in patients over 30 years old.

Conclusions

Highly suspicious thyroid nodules ≤ 10 mm in young patients tended to be more progressive. The predictors of disease progression were distinct in patients of different ages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–7.

    Article  CAS  PubMed  Google Scholar 

  2. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–22.

    Article  PubMed  Google Scholar 

  3. Park S, Oh CM, Cho H, et al. Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study. BMJ. 2016;355:i5745.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Li M, Dal Maso L, Vaccarella S. Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 2020;8(6):468–70.

    Article  PubMed  Google Scholar 

  5. Brenner DR, Weir HK, Demers AA, et al. Projected estimates of cancer in Canada in 2020. CMAJ. 2020;192(9):E199–205.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Patel KN, Yip L, Lubitz CC, et al. The American Association of endocrine surgeons guidelines for the definitive surgical management of thyroid disease in adults. Ann Surg. 2020;271(3):e21-93.

    Article  PubMed  Google Scholar 

  7. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sugitani I, Ito Y, Takeuchi D, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma. Thyroid. 2021;31(2):183–92.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.

    Article  PubMed  Google Scholar 

  10. Tuttle RM, Fagin JA, Minkowitz G, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1015–20.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Sakai T, Sugitani I, Ebina A, et al. Active surveillance for T1bN0M0 papillary thyroid carcinoma. Thyroid. 2019;29(1):59–63.

    Article  PubMed  Google Scholar 

  12. Fukuoka O, Sugitani I, Ebina A, et al. Natural history of asymptomatic papillary thyroid microcarcinoma: time-dependent changes in calcification and vascularity during active surveillance. World J Surg. 2016;40(3):529–37.

    Article  PubMed  Google Scholar 

  13. Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34(1):28–35.

    Article  PubMed  Google Scholar 

  14. Nagaoka R, Ebina A, Toda K, et al. Multifocality and progression of papillary thyroid microcarcinoma during active surveillance. World J Surg. 2021;45(9):2769–76.

    Article  PubMed  Google Scholar 

  15. Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Liu C, Zhao H, Xia Y, et al. Active surveillance of highly suspicious thyroid nodules cohort in China shows a worse psychological status in younger patients. Front Oncol. 2022;12:981495.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Zanocco KA, Hershman JM, Leung AM. Active surveillance of low-risk thyroid cancer. JAMA. 2019;321(20):2020–1.

    Article  PubMed  Google Scholar 

  18. Oh HS, Ha J, Kim HI, et al. Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea. Thyroid. 2018;28(12):1587–94.

    Article  PubMed  Google Scholar 

  19. Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34(6):1222–31.

    Article  PubMed  Google Scholar 

  20. Vasileiadis I, Karakostas E, Charitoudis G, et al. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients. Eur J Clin Investig. 2012;42(6):657–64.

    Article  Google Scholar 

  21. Cappelli C, Castellano M, Braga M, et al. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol. 2007;95(7):555–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by a grant provided by the Capital Clinical Features Application Research (Z171100001017211).

Author information

Author notes

  1. Lingdun Zhuge and Zehao Huang contributed equally to this article.

Authors and Affiliations

  1. Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Lingdun Zhuge MD, Zehao Huang MD, Huizhu Cai MD, Shixu Wang MD, Lijuan Niu MD & Zhengjiang Li MD

Authors
  1. Lingdun Zhuge MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zehao Huang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huizhu Cai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shixu Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lijuan Niu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhengjiang Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhengjiang Li MD.

Ethics declarations

Disclosures

All authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 15 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhuge, L., Huang, Z., Cai, H. et al. The Optimal Age Threshold for Stratifying the Risks of Disease Progression in Patients with Highly Suspicious Sub-centimeter Thyroid Nodules. Ann Surg Oncol 30, 5463–5469 (2023). https://doi.org/10.1245/s10434-023-13497-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13497-1

Search

Navigation